Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-17
2011-05-17
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S323000
Reexamination Certificate
active
07943629
ABSTRACT:
The invention relates to sulphimides as protein kinase inhibitors of the general formula I
REFERENCES:
patent: 2005/0176743 (2005-08-01), Luecking et al.
patent: WO 2005/037800 (2005-04-01), None
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Cohen et al., Current Opinion in Chemical Biology, 3, 459-465, 1999.
Dermer et al., Bio/Technology, 1994, 12:320.
Freshney et al., Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, pp. 1-6.
Golub et al., Science, 266, 531-537, 1993.
Mass, R.D., Int. J. Radiation Oncology Bio Phys. vol. 58(3):932-940, 2004.
Fabbro et al., Pharmacology & Therapeutics 93 (2002), pp. 79-98.
Powell et al., British Journal of Dermatology, 141:802-810, 1999.
Tohru Ueda, et al.; “Nucleosides XVII. Pyrimidinyl Amino Acids”; J. Med Chem.; 1963; Bd. 6; pp. 697-700.
Simon F. Campbell, et al.; “2, 4-Diamino-6,7,-dimethoxyquinazolines.3. 2-(4-heterocyclylpiperazin-1-yl) derivatives . . . ” J. Med. Chem.; 1987; Bd. 30; pp. 1794-1798.
Polina I. Svirskaya, et al.; “Fluorinated heterocyclic compounds. 2. 2, 4-difluoro and 4-amino-2-fluoropyrimidines, nucleoside base analogs”; J. Heterocycl. Chem.; 1985; pp. 149-153.
Giorgio Caravatti, et al.; “Structure based design of a non-peptidic antagonist of the SH2 domain of GRB2”; Bioorg. Med. Chem. Lett.; 1999; pp. 1973-1978; Bd. 9.
G.B. Barlin; “Kinetics of reactions in heterocycles”; J. Chem. Soc. (B); 1967; pp. 954-958.
Kondratenko, et al.; “S-trifluoromethyl-S-aryl-N-trifluoromethylsulfonylsulfimides”; Zhurnal Organicheskoi Khimii; 1984; pp. 2599-2604; Bd. 20, Nr. 12; Chemical Abstracts Service, Database accession No. 102:220513.
Kenneth K. Andersen, et al.; “Antimalarial sulfilimines and sulfoximines related to diaminodiphenyl sulfoxide and sulfone”; J. Med. Chem.; 1970; pp. 759-760; Bd. 13, Nr. 4.
Doecke Wolf-Dietrich
Jautelat Rolf
Luecking Ulrich
Nguyen Duy
Siemeister Gerhard
Bayer Schering Pharma AG
Millen White Zelano & Branigan P.C.
Rao Deepak
LandOfFree
Sulphimides as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulphimides as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulphimides as protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2693009